维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="DOCKE W D"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Interleukin 10 treatment of psoriasis显示文摘	Asadullash K Docke W D Ebeling M	1999	Arch Dermatol1999，135，：	1
2	Immunomodulation by intedeukin-lO therapy decreases the incidence of relapse and prolongs the relapse-free interval in psoriasis显示文摘	FRIEDRICH M DOCKE W D KLEIN A	2002	J Invest Dermatol2002，118，4：	1
3	Hyperprocalcitoniemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass显示文摘	Hensel M Volk T Docke W D et a1	1998	Anesthesiology1998，89，1：	1
4	Comprehensive bio- marker monitoring in cytokine therapy: heterogeneous, time-de- pendent, and persisting immune effects of interleukin-10 applica- tion in psoriasis显示文摘	Docke W D Asadullah K Belbe G	2009	J Lecukoc Biol2009，85，3：	1
5	Monocyte deactivation in septic patients: Restoration by interferon- γ treatment显示文摘	DOCKE W D RANDOW F SYRBE U	1997	Nat Med1997，3，：	1
6	Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass 显示文摘	HENSEL M VOLK T DOCKE W D	1998	Anesthesiology1998，89，1：	1
7	Comprehensive biomark- er monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of interleukin-10 application in psoria- sis 显示文摘	Docke W D Asadullah K Belbe G	2009	J Leukocyte Biol2009，85，3：	1
8	Monocyte deactivation in septic patients: restoration by interferon gamma treatment显示文摘	DOCKE W D RANDOW F SYRBE U	1997	Nat Med1997，3，：	1
9	Prevention of demasculinization and feminization of the brain in prenatally stressed male rats:by prenatal androgen treatment显示文摘	Domer G Docke W D	1983	Exp Clin Endocr1983，81，1：	1
10	Impaired antigen presentation by human monocytes during endotoxin tolerance显示文摘	Docke W D Von Baaehr V	2000	Blood2000，96，2：	1
11	Impaired antigen presentation by human monocytes during endotoxin tolerance显示文摘	Wolk K Docke W D von Baehr V	2000	Blood2000，96，1：	1
12	Clinical aspects: from systemic inflammation to 'immunoparalysis'显示文摘	VOLK H D REINKE P DOCKE W D	2000	Chem Immunol2000，74，1：	1
13	Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in Psoriasis显示文摘	Friedrich M Docke W D Klein A	2002	J Invest Dermatol2002，118，4：	1
14	Superior nuclear receptor selectivity and therapeutic index of methylprednisolone aceponate versus mometasone furoate 显示文摘	Mirshahpanah P Docke W D Merbold U	2007	Experimental dermatology2007，16，9：	1
15	Clinical aspects:from systemic inflammation to '' immunoparalysis''显示文摘	Volk H D Reinke P Docke W D	2000	Chem Immunol2000，74，：	1
16	Impaired antigen presentatio n by human monocytes during endotoxin tolerance显示文摘	Wolk K Docke W D von Baehr V	2000	Blood2000，1996，1：	1
17	Mechanisms in- volved in the side effects of gluco-corticoids显示文摘	Schacke H Docke W D Asadullah K	2002	Phar- macol Ther2002，96，1：	1
18	Dissocia- tion of transactivation from transrep-ression by a se- lective glucoeorticoid receptor agonist leads to separa- tion of therapeutic effe-cts from side effects显示文摘	Schack H Schottelius A Docke W D	2004	Proc- Natl Acad Set USA2004，101，1：	1
19	Monocyte deactivation in septic patients: restoration by IFN-gamma treatment 显示文摘	Docke W D Randow F Syrbe U	1997	Nat Med1997，3，6：	1
20	Clinical aspects:from systemic inflammation to 'immunoparalysis显示文摘	Volk H D Reinke P Docke W D	2000	Chem Immunol2000，74，12：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示